|
End-of-day quote
NSE India S.E.
13/08/2026
|
5-day change | 1st Jan Change | ||
| 2,009.60 INR | 0.00% |
|
+3.76% | +47.28% |
| 07/08 | Emcure Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 06, 2026 | |
| 06/08 | Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| Market Cap | 381B 3.99B 3.46B 3.24B 2.96B 5.57B 5.65B 38.19B 14.91B 191B 14.99B 14.66B 636B | P/E 2026 |
32.7x | P/E 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 388B 4.06B 3.52B 3.3B 3.01B 5.66B 5.75B 38.87B 15.18B 194B 15.25B 14.92B 647B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.66x |
| Free-Float |
18.23% | Yield 2026 |
0.23% | Yield 2027 * | 0.2% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 week | +3.76% | ||
| Current month | +2.53% | ||
| 1 month | +12.06% | ||
| 3 months | +21.28% | ||
| 6 months | +34.99% | ||
| Current year | +47.28% |
| 1 week | 1,967 |  | 2,048 |
| 1 month | 1,751 | | 2,048 |
| Current year | 1,381 | | 2,048 |
| 1 year | 1,260 | | 2,048 |
| 3 years | 889 | | 2,048 |
| 5 years | 889 | | 2,048 |
| 10 years | 889 | | 2,048 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 73 | 23/07/2001 | |
| Director/Board Member | 75 | 16/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +3.76% | +38.23% | - | 3.99B | |
| -2.12% | -0.95% | +71.60% | +118.30% | 1,078B | |
| -0.65% | +0.41% | +48.99% | +50.09% | 632B | |
| -0.74% | +1.09% | +21.51% | +63.33% | 443B | |
| -2.44% | -3.70% | +41.42% | +33.55% | 356B | |
| -1.87% | -3.76% | +23.00% | +33.35% | 289B | |
| -2.25% | -3.73% | -1.16% | +3.04% | 245B | |
| -1.32% | +0.14% | +41.76% | +57.68% | 226B | |
| -0.77% | -2.79% | -8.60% | -52.11% | 204B | |
| -0.95% | +2.83% | +15.09% | +71.55% | 171B | |
| Average | -1.29% | +1.45% | +29.18% | +42.09% | 364.77B | |
| Weighted average by Cap. | -1.51% | +1.30% | +40.90% | +61.54% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 959M 832M 780M 711M 1.34B 1.36B 9.18B 3.58B 45.83B 3.6B 3.52B 153B | 106B 1.11B 962M 902M 822M 1.55B 1.57B 10.62B 4.15B 53.02B 4.17B 4.08B 177B |
| Net income | 9.81B 103M 89.1M 83.53M 76.16M 143M 146M 983M 384M 4.91B 386M 378M 16.38B | 11.94B 125M 108M 102M 92.71M 174M 177M 1.2B 467M 5.98B 470M 460M 19.94B |
| Net Debt | 6.75B 70.72M 61.3M 57.46M 52.39M 98.58M 100M 677M 264M 3.38B 265M 260M 11.27B | 6.38B 66.89M 57.98M 54.35M 49.56M 93.25M 94.75M 640M 250M 3.2B 251M 246M 10.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | INR 2,009.60 | 0.00% | 54,656 |
| 12/08/26 | INR 2,009.60 | +0.55% | 214,106 |
| 11/08/26 | INR 1,998.70 | +0.18% | 97,589 |
| 10/08/26 | INR 1,995.20 | +0.85% | 205,967 |
| 07/08/26 | INR 1,978.40 | +2.15% | 145,070 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
